TY - JOUR AU - Shaw, J. E. AU - Sicree, R. A. AU - Zimmet, P. Z. PY - 2010 DA - 2010// TI - Global estimates of the prevalence of diabetes for 2010 and 2030 JO - Diabetes Res Clin Pract VL - 87 UR - https://doi.org/10.1016/j.diabres.2009.10.007 DO - 10.1016/j.diabres.2009.10.007 ID - Shaw2010 ER - TY - JOUR AU - Whiting, D. R. AU - Guariguata, L. AU - Weil, C. AU - Shaw, J. PY - 2011 DA - 2011// TI - IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 JO - Diabetes Res Clin Pract VL - 94 UR - https://doi.org/10.1016/j.diabres.2011.10.029 DO - 10.1016/j.diabres.2011.10.029 ID - Whiting2011 ER - TY - JOUR AU - Guariguata, L. PY - 2012 DA - 2012// TI - By the numbers: new estimates from the IDF diabetes atlas update for 2012 JO - Diabetes Res Clin Pract VL - 98 UR - https://doi.org/10.1016/j.diabres.2012.11.006 DO - 10.1016/j.diabres.2012.11.006 ID - Guariguata2012 ER - TY - JOUR AU - Kramer, H. AU - Molitch, M. E. PY - 2005 DA - 2005// TI - Screening for kidney disease in adults with diabetes JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.7.1813 DO - 10.2337/diacare.28.7.1813 ID - Kramer2005 ER - TY - JOUR AU - Go, A. S. AU - Chertow, G. M. AU - Fan, D. AU - McCulloch, C. E. AU - Hsu, C. Y. PY - 2004 DA - 2004// TI - Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041031 DO - 10.1056/NEJMoa041031 ID - Go2004 ER - TY - JOUR AU - Arjona Ferreira, J. C. AU - Marre, M. AU - Barzilai, N. AU - Guo, H. AU - Golm, G. T. AU - Sisk, C. M. PY - 2013 DA - 2013// TI - Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-1365 DO - 10.2337/dc12-1365 ID - Arjona Ferreira2013 ER - TY - JOUR AU - Patel, A. AU - MacMahon, S. AU - Chalmers, J. AU - Neal, B. AU - Billot, L. PY - 2008 DA - 2008// TI - Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0802987 DO - 10.1056/NEJMoa0802987 ID - Patel2008 ER - TY - JOUR AU - Inzucchi, S. E. PY - 2002 DA - 2002// TI - Oral antihyperglycemic therapy for type 2 diabetes: scientific review JO - JAMA VL - 287 UR - https://doi.org/10.1001/jama.287.3.360 DO - 10.1001/jama.287.3.360 ID - Inzucchi2002 ER - TY - JOUR AU - Nabeno, M. AU - Akahoshi, F. AU - Kishida, H. AU - Miyaguchi, I. AU - Tanaka, K. AU - Ishii, S. PY - 2013 DA - 2013// TI - A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site JO - Biochem Biophys Res Commun VL - 434 UR - https://doi.org/10.1016/j.bbrc.2013.03.010 DO - 10.1016/j.bbrc.2013.03.010 ID - Nabeno2013 ER - TY - JOUR AU - Bergman, A. J. AU - Stevens, C. AU - Zhou, Y. AU - Yi, B. AU - Laethem, M. AU - Smet, M. PY - 2006 DA - 2006// TI - Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers JO - Clin Ther VL - 28 UR - https://doi.org/10.1016/j.clinthera.2006.01.015 DO - 10.1016/j.clinthera.2006.01.015 ID - Bergman2006 ER - TY - JOUR AU - Chan, J. C. AU - Scott, R. AU - Arjona Ferreira, J. C. AU - Sheng, D. AU - Gonzalez, E. AU - Davies, M. J. PY - 2008 DA - 2008// TI - Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00914.x DO - 10.1111/j.1463-1326.2008.00914.x ID - Chan2008 ER - TY - JOUR AU - Otsuki, H. AU - Kosaka, T. AU - Nakamura, K. AU - Shimomura, F. AU - Kuwahara, Y. AU - Tsukamoto, T. PY - 2014 DA - 2014// TI - Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes JO - Int Urol Nephrol VL - 46 UR - https://doi.org/10.1007/s11255-013-0552-6 DO - 10.1007/s11255-013-0552-6 ID - Otsuki2014 ER - TY - JOUR AU - Vaidya, V. S. AU - Waikar, S. S. AU - Ferguson, M. A. AU - Collings, F. B. AU - Sunderland, K. AU - Gioules, C. PY - 2008 DA - 2008// TI - Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans JO - Clin Transl Sci VL - 1 UR - https://doi.org/10.1111/j.1752-8062.2008.00053.x DO - 10.1111/j.1752-8062.2008.00053.x ID - Vaidya2008 ER - TY - JOUR PY - 2012 DA - 2012// TI - KDOQI clinical practice guideline for diabetes and CKD: 2012 update JO - Am J Kidney Dis VL - 60 UR - https://doi.org/10.1053/j.ajkd.2012.07.005 DO - 10.1053/j.ajkd.2012.07.005 ID - ref14 ER - TY - JOUR AU - Hamburg, N. M. AU - Keyes, M. J. AU - Larson, M. G. AU - Vasan, R. S. AU - Schnabel, R. AU - Pryde, M. M. PY - 2008 DA - 2008// TI - Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study JO - Circulation VL - 13 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.748574 DO - 10.1161/CIRCULATIONAHA.107.748574 ID - Hamburg2008 ER - TY - JOUR AU - Matsubara, J. AU - Sugiyama, S. AU - Akiyama, E. AU - Iwashita, S. AU - Kurokawa, H. AU - Ohba, K. PY - 2013 DA - 2013// TI - Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes JO - Circulation VL - 77 UR - https://doi.org/10.1253/circj.CJ-12-1168 DO - 10.1253/circj.CJ-12-1168 ID - Matsubara2013 ER - TY - JOUR AU - Taguchi, I. AU - Toyoda, S. AU - Takano, K. AU - Arikawa, T. AU - Kikuchi, M. AU - Ogawa, M. PY - 2013 DA - 2013// TI - Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension JO - Hypertens Res VL - 36 UR - https://doi.org/10.1038/hr.2013.3 DO - 10.1038/hr.2013.3 ID - Taguchi2013 ER - TY - JOUR AU - Cornelli, U. AU - Terranova, R. AU - Luca, S. AU - Cornelli, M. AU - Alberti, A. PY - 2001 DA - 2001// TI - Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress JO - J Nutr VL - 131 ID - Cornelli2001 ER - TY - JOUR AU - Cesarone, M. R. AU - Belcaro, G. AU - Carratelli, M. AU - Cornelli, U. AU - Sanctis, M. T. AU - Incandela, L. PY - 1999 DA - 1999// TI - A simple test to monitor oxidative stress JO - Int Angiol VL - 18 ID - Cesarone1999 ER - TY - JOUR AU - Chou, K. M. AU - Lee, C. C. AU - Chen, C. H. AU - Sun, C. Y. PY - 2013 DA - 2013// TI - Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0054863 DO - 10.1371/journal.pone.0054863 ID - Chou2013 ER - TY - JOUR AU - Araki, S. AU - Haneda, M. AU - Koya, D. AU - Sugaya, T. AU - Isshiki, K. AU - Kume, S. PY - 2013 DA - 2013// TI - Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-1298 DO - 10.2337/dc12-1298 ID - Araki2013 ER - TY - JOUR AU - Kamijo-Ikemori, A. AU - Sugaya, T. AU - Yasuda, T. AU - Kawata, T. AU - Ota, A. AU - Tatsunami, S. PY - 2011 DA - 2011// TI - Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc10-1392 DO - 10.2337/dc10-1392 ID - Kamijo-Ikemori2011 ER - TY - JOUR AU - Mori, H. AU - Okada, Y. AU - Arao, T. AU - Tanaka, Y. PY - 2014 DA - 2014// TI - Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus JO - J Diabetes Investig VL - 5 UR - https://doi.org/10.1111/jdi.12142 DO - 10.1111/jdi.12142 ID - Mori2014 ER - TY - JOUR AU - Kamijyo, A. AU - Kimura, K. AU - Sugaya, T. AU - Yamanouchi, M. AU - Hirano, N. AU - Hirata, Y. PY - 2004 DA - 2004// TI - Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease JO - J Lab Clin Med VL - 143 UR - https://doi.org/10.1016/j.lab.2003.08.001 DO - 10.1016/j.lab.2003.08.001 ID - Kamijyo2004 ER - TY - JOUR AU - Perkins, B. A. AU - Ficociello, L. H. AU - Ostrander, B. E. AU - Silva, K. H. AU - Weinberg, J. AU - Warram, J. H. PY - 2007 DA - 2007// TI - Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes JO - J Am Soc Nephrol VL - 18 UR - https://doi.org/10.1681/ASN.2006080872 DO - 10.1681/ASN.2006080872 ID - Perkins2007 ER - TY - JOUR AU - Torimoto, K. AU - Okada, Y. AU - Mori, H. AU - Tanaka, Y. PY - 2013 DA - 2013// TI - Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-1 DO - 10.1186/1475-2840-12-1 ID - Torimoto2013 ER - TY - JOUR AU - Matsuzawa, Y. AU - Sugiyama, S. AU - Sugamura, K. AU - Nozaki, T. AU - Ohba, K. AU - Konishi, M. PY - 2010 DA - 2010// TI - Digital assessment of endothelial function and ischemic heart disease in women JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2009.10.073 DO - 10.1016/j.jacc.2009.10.073 ID - Matsuzawa2010 ER - TY - JOUR AU - Matsuzawa, Y. AU - Sugiyama, S. AU - Sumida, H. AU - Sugamura, K. AU - Nozaki, T. AU - Ohba, K. PY - 2013 DA - 2013// TI - Peripheral endothelial function and cardiovascular events in high-risk patients JO - J Am Heart Assoc VL - 25 UR - https://doi.org/10.1161/JAHA.113.000426 DO - 10.1161/JAHA.113.000426 ID - Matsuzawa2013 ER - TY - JOUR AU - Fujisue, K. AU - Sugiyama, S. AU - Ono, T. AU - Matsuzawa, Y. AU - Akiyama, E. AU - Sugamura, K. PY - 2013 DA - 2013// TI - Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease JO - Circ Cardiovasc Interv VL - 6 UR - https://doi.org/10.1161/CIRCINTERVENTIONS.112.000278 DO - 10.1161/CIRCINTERVENTIONS.112.000278 ID - Fujisue2013 ER - TY - JOUR AU - Nakamura, K. AU - Oe, H. AU - Kihara, H. AU - Shimada, K. AU - Fukuda, S. AU - Watanabe, K. PY - 2014 DA - 2014// TI - DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study JO - Cardiovasc Diabetol VL - 30 UR - https://doi.org/10.1186/s12933-014-0110-2 DO - 10.1186/s12933-014-0110-2 ID - Nakamura2014 ER - TY - JOUR AU - Tanaka, S. AU - Suzuki, K. AU - Aoki, C. AU - Niitani, M. AU - Kato, K. AU - Tomotsune, T. AU - Aso, Y. PY - 2014 DA - 2014// TI - Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy JO - Diabetes Technol Ther VL - 16 UR - https://doi.org/10.1089/dia.2014.0095 DO - 10.1089/dia.2014.0095 ID - Tanaka2014 ER - TY - JOUR AU - Nonaka, K. AU - Tsubouchi, H. AU - Okayama, K. AU - Fukao, Y. AU - Johnson-Levonas, A. O. AU - Amatruda, J. M. PY - 2009 DA - 2009// TI - Effects of once-daily sitagliptin on 24-h glucose control following 4 weeks of treatment in Japanese patients with type 2 diabetes mellitus JO - Horm Metab Res VL - 41 UR - https://doi.org/10.1055/s-0028-1100413 DO - 10.1055/s-0028-1100413 ID - Nonaka2009 ER - TY - JOUR AU - Kadowaki, T. AU - Kondo, K. PY - 2013 DA - 2013// TI - Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus JO - Diabetes Obes Metab VL - 15 UR - https://doi.org/10.1111/dom.12092 DO - 10.1111/dom.12092 ID - Kadowaki2013 ER - TY - JOUR AU - Ceriello, A. AU - Esposito, K. AU - Piconi, L. AU - Ihnat, M. A. AU - Thorpe, J. E. AU - Testa, R. PY - 2008 DA - 2008// TI - Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients JO - Diabetes VL - 57 UR - https://doi.org/10.2337/db08-0063 DO - 10.2337/db08-0063 ID - Ceriello2008 ER - TY - JOUR AU - Suzuki, K. AU - Olah, G. AU - Módis, K. AU - Colletta, C. AU - Kulp, G. AU - Gerö, D. PY - 2011 DA - 2011// TI - Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function JO - Proc Natl Acad Sci USA VL - 108 UR - https://doi.org/10.1073/pnas.1105121108 DO - 10.1073/pnas.1105121108 ID - Suzuki2011 ER - TY - JOUR AU - Rizzo, M. R. AU - Barbieri, M. AU - Marfella, R. AU - Paolisso, G. PY - 2012 DA - 2012// TI - Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc12-0199 DO - 10.2337/dc12-0199 ID - Rizzo2012 ER - TY - JOUR AU - Kimura, S. AU - Inoguchi, T. AU - Yamasaki, T. AU - Yamato, M. AU - Ide, M. AU - Sonoda, N. PY - 2016 DA - 2016// TI - A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: in vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats JO - Metabolism VL - 65 UR - https://doi.org/10.1016/j.metabol.2015.10.030 DO - 10.1016/j.metabol.2015.10.030 ID - Kimura2016 ER - TY - JOUR AU - Nakagami, H. AU - Pang, Z. AU - Shimosato, T. AU - Moritani, T. AU - Kurinami, H. AU - Koriyama, H. PY - 2014 DA - 2014// TI - The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome JO - Hypertens Res VL - 37 UR - https://doi.org/10.1038/hr.2014.53 DO - 10.1038/hr.2014.53 ID - Nakagami2014 ER - TY - JOUR AU - Scirica, B. M. AU - Bhatt, D. L. AU - Braunwald, E. AU - Steg, P. G. AU - Davidson, J. AU - Hirshberg, B. PY - 2013 DA - 2013// TI - SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1307684 DO - 10.1056/NEJMoa1307684 ID - Scirica2013 ER - TY - JOUR AU - White, W. B. AU - Cannon, C. P. AU - Heller, S. R. AU - Nissen, S. E. AU - Bergenstal, R. M. AU - Bakris, G. L. PY - 2013 DA - 2013// TI - EXAMINE investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305889 DO - 10.1056/NEJMoa1305889 ID - White2013 ER - TY - JOUR AU - Green, J. B. AU - Bethel, M. A. AU - Armstrong, P. W. AU - Buse, J. B. AU - Engel, S. S. AU - Garg, J. PY - 2015 DA - 2015// TI - TECOS study group. effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1501352 DO - 10.1056/NEJMoa1501352 ID - Green2015 ER - TY - JOUR AU - Fisman, E. Z. AU - Tenenbaum, A. PY - 2015 DA - 2015// TI - Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-015-0294-0 DO - 10.1186/s12933-015-0294-0 ID - Fisman2015 ER -